Faulty CDC Lyme Webpages. Do NOT Fund This Organization Any Longer

September 13, 2022

**UPDATE**

Go here to tell your Congressman, “Don’t give the CDC one more dime, and no more data collection.”

Go here to read WI Senator Ron Johnson’s letter to CDC’s Director Rachelle Walensky on the fact the CDC admits it gave false information about COVID shot surveillance.

  • It inaccurately responded to a FOIA request and stated it conducted a certain type of analysis more than a year before it actually did.
  • The CDC not only said that the team didn’t conduct any abstractions or reports through October 2021, but that “an association between myocarditis and mRNA COVID-19 vaccination was not known at that time.”
    That statement is false.
  • By April 2021, the U.S. military was raising the alarm about post-vaccination heart inflammation, and by June 2021, the CDC was publicly acknowledging a link
  • The CDC promised in January 2021 that it would perform a specific type of data mining analysis on the VAERS reports called proportional reporting ratio (PRR). But when asked by CHD for the results, the CDC said that “no PRRs were conducted by the CDC” and that data mining “is outside of [the] agency’s purview.”
  • Dr. John Su, who heads the CDC’s VAERS team, told The Epoch Times in an email that the CDC started performing PRRs in February 2021 “and continues to do so to date.”
  • The CDC is now saying that both the original response and Su’s statement are false.
  • The CDC states it “misinterpreted” the request despite the fact the FOIA request specifically mentioned PRRs and their response mentioned they did not do PRRs.  Nice try.

What does this mean?  The CDC was not analyzing VAERS for early warning safety signals for WELL OVER A YEAR after the “vaccination” campaign began.  Also, the CDC hasn’t released the PRR results. 

https://www.lymedisease.org/cdc-lyme-pages-need-modifications/

The CDC’s Lyme webpages need some serious modifications

Aug. 23, 2022

By Dorothy Kupcha Leland

Subcommittee reports from the federal Tick-Borne Disease Working Group are now available for you to read on the Health and Human Services website.

Should you care? Yes. And here’s why:

These reports will help the Working Group decide what to ask Congress to do about Lyme disease and other tick-related conditions.

One of the most important subcommittees to Lyme patients is “Access to Care.” It’s chaired by Dr. Elizabeth Maloney and Captain Rebecca Bunnell, of the US Public Health Service.

It deals with the many barriers that prevent people from getting properly diagnosed and treated for Lyme disease.

The group’s report focuses on three key factors that account for many of the health disparities that patients with tick-borne illnesses experience:

  • Patient-encountered barriers,
  • Clinician-encountered barriers, and
  • Medical educational barriers.

What does CDC website say about Lyme disease?

While there are a lot of nuggets in this report, I’d like to highlight the section that focuses on what the CDC website says about Lyme disease.

This is often one of the first places that patients (and their doctors) turn to for information. As a result, it’s one of the first barriers placed in the path of Lyme patients in need of treatment.

The report states:

  • The content [of the CDC’s Lyme webpages] does not provide an accurate review of the current body of knowledge and fails to acknowledge what remains unknown, what is uncertain, and what continues to be debated [about Lyme disease].
  • The webpages miss the opportunity to fully describe this multifaceted disease, its many and varied presentations, and the consequences of missed and delayed diagnosis and treatment. Although much of the content is factual, it lacks sufficient depth and, at times, perpetuates common misconceptions.
  • The webpages on signs and symptoms do not provide detailed information regarding potential disease symptoms and signs or elements of the medical history that make Lyme disease more or less likely. Therefore, clinicians are ill-equipped to estimate patient-specific, pre-test probabilities. The section on diagnostic testing does not adequately discuss the well-known limitations of serologic testing.
  • Treatment recommendations do not acknowledge the low quality of the available evidence on which they were based and leave no apparent room for clinicians to exercise clinical judgment or engage in shared decision-making.
  • Although a limited list of references follows the treatment recommendations for erythema migrans, Lyme carditis, neurologic Lyme disease, and Lyme arthritis , these references do not appear to represent a systematic and comprehensive review of the pertinent evidence. Hand-cultivated lists are problematic because they often reflect the anchoring and confirmation biases of those selecting the evidence to be reviewed, which may perpetuate particular points of view, or even errors.
  • The content regarding PLD/CLD  [persistent Lyme disease/chronic Lyme disease] appears skewed in that it does not provide clinically helpful information or references regarding the condition, potential etiologies, knowns and unknowns, or the diverse and often conflicting scientific viewpoints that mark this challenging health problem. The list of references is overly weighted toward the risks associated with treatment and provides an inaccurate assessment of the potential benefits.
  • Although information about the scientific evidence may be too detailed for the general public, it could and should be included on the “health care providers” webpage. At present, this webpage offers an inaccurate portrayal of the available scientific evidence and current state of clinical uncertainties. This is best exemplified by including a video of a patient discussing his misdiagnosis of Lyme disease while omitting any discussion or videos of patients with Lyme disease whose lives were irretrievably altered by diagnostic and therapeutic delays when Lyme disease was erroneously diagnosed as something else, or the complex problem of PLD/CLD.

So what to do about it?

Later in the report, the subcommittee recommends:

Fund and support a directive for CDC to conduct a review of CDC webpages and the current CDC TRAIN CME [continuing education modules] pertaining to the prevention, diagnosis, and treatment of Lyme disease to determine whether they best reflect the current state of the science and appropriately delineate areas of scientific uncertainty.

Sounds like a pretty good idea, don’t you think?

CDC Director Dr. Rochelle Walensky recently called for an organizational overhaul of the CDC, due to the agency’s missteps during the COVID pandemic.

A similar overhaul is needed for all the CDC’s missteps related to Lyme disease–including correcting the website problems listed above.

I hope the Working Group takes the subcommittee’s advice, and asks Congress to fix this–pronto.

Here are links to all the subcommittee reports:

2022 Subcommittee Reports

2022 Access to Care Subcommittee Report to the Tick-Borne Disease Working Group

2022 Clinical Presentation and Pathogenesis Subcommittee Report to the Tick-Borne Disease Working Group

2022 Diagnostics Subcommittee Report to the Tick-Borne Disease Working Group

2022 Disease Prevention and Treatment Subcommittee Report to the Tick-Borne Disease Working Group

2022 Tick Ecology Subcommittee Report to the Tick-Borne Disease Working Group

Next meeting of the Working Group is October 4-5. As usual, the public can tune in to watch it live. We’ll post details of that meeting when they become available.

TOUCHED BY LYME is written by Dorothy Kupcha Leland, Board President of LymeDisease.org. She is co-author of When Your Child Has Lyme Disease: A Parent’s Survival Guide. Contact her at dleland@lymedisease.org.

__________________

**Comment**

I couldn’t disagree more with the recommendation to “fund the CDC to conduct a review of CDC webpages and the current CDC TRAIN CME [continuing education modules].

Are you for real?

The corruption, fraud, and collusion in this organization is long, prolific, and shows no signs of slowing.

This organization needs to go now!

An independent inquiry made by folks without conflicts of interests (receiving funding from Big Pharma, government, etc) into the mishandling of Lyme/MSIDS.  When will Lyme advocates learn, acknowledge, and act upon the fact that working with an enemy of 40 years has been a waste of time, effort, and tax dollars – not to mention stressful and fruitless?

DEFUND the CDC & break the public health monopoly!

Category:

Activism, Lyme

Comments Off on Faulty CDC Lyme Webpages. Do NOT Fund This Organization Any Longer

Celebrating “Generation Lyme Day” On Sept. 24

https://www.lymedisease.org/generation-lyme-day-2022/

Celebrating “Generation Lyme Day” on Sept. 24

by Jennifer Hoffmann, Generation Lyme board member

There was no holiday to celebrate the people of the Lyme community. So we created one.

On Saturday, September 24th, Generation Lyme will host the second annual Generation Lyme Day.

It’s an all-day virtual event honoring everyone whose lives are impacted by Lyme disease. We will celebrate each other for who we are, far beyond our illness, and recognize wherever we are in our journeys.

Generation Lyme is a community for people battling Lyme disease. We know how isolating it can be to live with Lyme, and we’re here to change that.

Meet-Ups

We host online Meet-Ups several times a week for patients, parents, partners, and supporters. We have a growing roster of dedicated volunteer hosts and cover several needs, with Meet-Ups for parents, partners, supporters, late-nighters, international participants, men, women, college students, and the BIPOC and LGBTQIA+ communities.

Gen Lyme Meet-Ups are ideal places to ask questions, share what’s on your mind, or just listen. You can connect in a safe space with people who understand what you’re going through and make new friends. We also share patient stories to show what it’s like to live with Lyme disease and help people connect with others who understand.

Facilitated by our Generation Lyme Board–Jesse Ruben, Brooke Stoddard, Haley DiBiase, and Jennifer Hoffmann, Gen Lyme Day is a holiday worth celebrating. It’s a day to bring us together, offer compassion, and uniquely uplift our cause.

The event will feature fun, relaxing, at-home ways to enjoy a day as a community. We will share stories, amplify diverse voices, go live on social media throughout the day, interview guests from across the country, record a live episode of The Generation Lyme Podcast, host a Meet-Up, and have an after-party (with a concert)!

Our message is simple: We see you, we hear you, we value you, and we celebrate you. We are thrilled to bring joy to a community that doesn’t get to experience it often enough.

You can join Gen Lyme Day from wherever you are. It’s an experience that anyone and everyone can attend for free and from home. Gen Lyme Day is for you whether you’re feeling symptomatic, unusually great, or anything in between. The reality of your experience is welcome.

For more about how to participate in this year’s Gen Lyme Day, click here.

To view everything we did in 2021, click here.

Join us on Saturday, September 24th, for the second annual Gen Lyme Day!

Generation Lyme is an initiative of Project Lyme, a 501(c)3 nonprofit dedicated to tick-borne disease research, education, advocacy, and patient support.

Category:

Activism, Lyme

Comments Off on Celebrating “Generation Lyme Day” On Sept. 24

Private Medicine Trumps Private Equity

September 12, 2022

Private Medicine Trumps Private Equity

By Marilyn M. Singleton, MD JD –https://marilynsingletonmdjd.com/

Over the last couple of years, we’ve been living in a frenzied political atmosphere of inflation worries, unaddressed crime, Covid, monkeypox, and a variety of social issues. These are distractions from thinking about the big picture: the march toward government and corporate control over our lives, including absorbing medical practice into the statist-corporate complex.

While many say that COVID-19 brought out the flaws in public health, it has also highlighted the joys and advantages of private practice medicine. People who are disappointed in the oft-times unscientific public health recommendations and mandates have benefited from seeking advice from private practitioners. Sadly, we are on the road to losing private practice, the heart of good medicine.

A recent article about a private equity purchase of a small rural hospital chronicled in great detail how the firm ran the hospital into the ground. The residents were left with no hospital in their area. That was but one example. Until the last 10 or 15 years, most hospitals were owned either by mainly religious nonprofit entities or by states and cities, with ties to medical schools. Private equity ventures have quadrupled over the last 10 years, and have spent approximately $750 billion during that time period. As Bain Capital put it, 2021 was a “banner year” fueled by an aging population and more chronic illnesses. Private equity firms now control a large swath of hospitals, physician practices, ERs, nursing homes, and hospice centers.

For years, health policy experts have been warning about the dangers of private equity and consolidation in medical services. The focus on return on investment by private equity owners puts profits over patients. One study found that hospitals increased their prices after being acquired by private equity firms. Additionally, studies in nursing homes and dialysis centers have found private equity ownership is associated with not only higher prices, but a decrease in quality of care.

Concurrently, consolidation has been on a roll. Five for-profit insurers now control 43 percent of the market, more than 60 percent of community hospitals belong to a health system, and less than half of physicians own part of a private practice. A large California study found that consolidation of the hospital, physician, and insurance markets increased prices of services as well as ACA premiums. ….

Legally, there is not much we can do about it except protest with our feet. Seek out private practices where you are treated as an individual human being, not an income generator. The ideal practice is a cash-based practice or direct primary or specialty care practice. With direct primary care, a monthly fee covers all doctor visits, drugs dispensed at the office at wholesale prices, and 24/7 access to your doctor. Odd as it may seem, paying cash to see the doctor or have outpatient surgery can be less expensive than buying insurance with its co-pays and high deductibles. All you really need is hospital insurance (unless you are a billionaire). ….

It is up to us to save the patient-physician relationship – and just maybe our republic!

READ FULL ARTICLE: https://aapsonline.org/private-medicine-trumps-private-equity/

__________________

**Comment**

Hopefully, more hospitals will see the light in offering options to patients and will choose patient health and ethics over the dangling carrot of Federal reimbursement. The best way to protest is with your feet. Independent doctors are saving lives, despite being heavily persecuted. They saved mine.

For more:

Category:

Activism

Comments Off on Private Medicine Trumps Private Equity

Hospital With Patient Options Enters 9th Month Without Federal Reimbursement. Despite “Vaccine” Mandates Being Dropped, Wisconsin Healthcare Workers Who Had Exemptions Must Get Novavax Shot Or Lose Job

https://www.theepochtimes.com/hospital-that-allows-for-patient-options-in-healthcare-enters-ninth-month-without-federal-reimbursement

Hospital That Allows for Patient Options in Healthcare Enters Ninth Month Without Federal Reimbursement

By Matt McGregor
September 3, 2022

An independent community hospital in Texas, known for allowing patients to choose individualized care plans, is entering its ninth month without Medicare reimbursement for reasons one patient advocate says “don’t add up.”

The Centers for Medicare and Medicaid Services (CMS) terminated its agreement with United Memorial Medical Center (UMMC) on Jan. 11, 2022, “based on continued serious findings of deficiencies” showing a “failure to meet the minimum required patient safety and quality standards,” CMS told The Epoch Times.  (See link for article)

__________________

SUMMARY:

  • Priscilla Romans, a former nurse who exited government funded medicine, and owner of the patient-advocacy business Graith Care, has had clients flown to this independent hospital due to the fact they give patients options – not just the top down dictates of the federal government which has bribed hospitals with money to conform to their policies.
  • Romans states there are 64 million enrolled Medicare patients who deserve access to the care options they want.
  • CMS, through the CARES act, reimburses (bribes) hospitals for using “brutal” COVID treatment protocols known as the Fauci death protocol, which includes remdesivir, which is known to be toxic and kills 53% of those who take it. 
  • Hospitals make more money if you die from COVID than if you recover.
  • One such patient option was the Front Line COVID-19 Critical Care Alliance (FLCCC) treatment protocols, which include hydroxychloroquine, zinc, and vitamin C.
  • Attorney Tom Renz asks why CMS hasn’t investigated the hospital that malnourished and neglected the patient who was moved to another facility.  (As with Lyme literate doctors, investigations such as these nit-pick until they find any little nit – making the doctor/hospital look bad.  It’s really a form of punishment for dissenters, not that infractions don’t ever occur, but they occur everywhere, particularly when hospitals are busy and crowded).
  • Hospitals are taking patients off ventilators without informed consent and without family involvement. When relatives advocate for their loved ones to keep them vented, they are told their position “isn’t supported by science.” In one case a judge sided with the family member and helped organize a transfer to a new facility.  The patient was found to be malnourished, dehydrated, and 30 lbs underweight – clear signs of patient neglect.  He made tremendous progress at the new facility but died essentially due to how he was treated for so long at the first facility.
  • Similarly to Dr. Simon Gold a medical doctor and also an attorney who started America’s Frontline Doctors, who was unfairly arrested and is now doing jail time for a misdemeanor simply for peacefully speaking at the Capital in January, UMMC is being used as an example to other hospitals to show what happens to those who don’t toe the line.
Welcome to the New Normal.

_________________

https://www.axios.com/2022/09/09/companies-are-dropping-vaccine-mandates

Sep 9, 2022

Companies are dropping vaccine mandates

Illustration: Sarah Grillo/Axios

Excerpts:

Some companies are rolling back mandates for employee COVID vaccination — but few are making official public statements about it.

Why it matters: These moves signal that we’ve shifted into a new chapter of the pandemic — and that employers are desperate to get people back to the office.

What’s happening: “[Companies] decided that the rationale for [mandates] had become weak enough that they don’t want to continue,” Jeff Levin-Scherz, population health leader at Willis Towers Watson, tells Axios.

Zoom out: The White House yesterday called on businesses to take certain actions to protect employees and customers from COVID-19 this fall. Mandates weren’t on the list.

Yet, despite the fact these injections don’t stop transmission, infection, severe illness, or even death – and have actually been linked with more reports of severe reactions and death than any other “vaccine” in the history of VAERS, which historically only captures 1% of reactions:

Wisconsin Healthcare Workers Who Had Religious, Medical Exemptions Must Get Novavax COVID Shot or Lose Job

A Wisconsin hospital this week said it is withdrawing medical and religious exemptions for some employees from the hospital’s COVID-19 vaccine mandate, giving those employees until Sept. 21 to get the Novavax vaccine.

The hospital is Froedtert & the Medical College of Wisconsin, which operates 11 hospitals and more than 45 health centers and clinics throughout the midwest and employs more than 2,000 physicians.

Novavax was granted Emergency Use Authorization (EUA) in July.  Prior COVID-19 shots made by Pfizer, Moderna and Johnson & Johnson used fetal cell lines from unborn fetuses in various stages of development and testing, but the Novavax shot is a protein-based technology purposely created to entice “vaccine” holdouts with ethical concerns about using human fetal cell lines.

But, per usual, few are talking about safety and efficacy.
The ones that are have been jailed, discredited, and bullied.  And the list keeps growing.

Dr. Meryl Nass, a member of the Children’s Health Defense (CHD) scientific advisory committee, pointed out that the Novavax shot contains a novel adjuvant, Matrix-M, “so it is not really an old-fashioned shot.”

Category:

Activism, Treatment, vaccines, Viruses

Comments Off on Hospital With Patient Options Enters 9th Month Without Federal Reimbursement. Despite “Vaccine” Mandates Being Dropped, Wisconsin Healthcare Workers Who Had Exemptions Must Get Novavax Shot Or Lose Job

Andrographis

https://vitalplan.com/ingredients/andrographis

Andrographis

By Vital Plan

Reviewed by Bill Rawls, MD
Medical Director of Vital Plan

QUICK FACTS

Common name: Andrographis
Scientific name: Andrographis paniculata
Other names: King of bitters, kirta or kirata (Sanskrit), kiryata (Hindi), kalmegh (Bengali, Hindi, Unani), hempedu bumi (Malaysia), creat, green chiretta, Indian chiretta, chuan xin lian (traditional Chinese medicine)
Location: Native to India
Known for: Its bitter taste and potent antimicrobial and immune-supportive properties
Part Used: Aerial parts (leaf, stem, and flowers)
Fun fact: In Scandinavia, andrographis is a popular herbal flu remedy.1
Good for: Fighting acute and chronic infections, immune health, microbiome balance, liver protection, proper bile flow
Key Properties & Actions: Antibacterial, antiviral, antifungal, antiparasitic, immunomodulating, hepatoprotective, digestive bitter tonic, cholagogue (stimulates bile flow), anti-inflammatory, antioxidant

Summary

Andrographis is a bitter-tasting herb renowned for its antimicrobial and immune-supportive effects. Native to India, it has long been used to support the immune system, digestion, and the liver. Modern research shows it can be helpful in fighting infections, as well as providing various other benefits.

What is Andrographis?

Andrographis is a shrubby annual plant whose intensely bitter leaves have led to its moniker, “king of bitters.” Growing one to three feet in height, this herb prefers the shady, moist habitat of a forest or wetland but is also seen growing in plains, hillsides, and farms. In the fall, andrographis bears small white flowers with brown or purple spots.

White flower and fresh green leaves of andrographis paniculata o

Although andrographis is native to India, it has been introduced to and can be found growing in China, Indonesia, Laos, Malaysia, Myanmar, Thailand, Vietnam, the islands of the Caribbean and West Indian Ocean, and parts of North America and Central America. In many areas, but especially in Asia, andrographis is prized as a traditional medicinal herb and often used for infections, fevers, and liver disorders.

In the last few decades, research on andrographis has increased, with in vitro (in a test tube or petri dish) and in vivo (in a living model) clinical studies confirming the traditional usages of the herb. Today, it is primarily used for its microbiome-balancing, immune-supportive, and liver-protective qualities, although it offers a variety of other health benefits.

Benefits of Andrographis and How It Works

Antimicrobial Support
Antibacterial Activity

For centuries, andrographis has been used to fight various kinds of infections, including those caused by bacteria, viruses, fungi, and parasites. In the last decade, scientific interest in andrographis has accelerated, with particular focus on its antimicrobial qualities.
Researchers have reported that andrographis extract possesses potent antibacterial activity against numerous kinds of bacteria.2

An in vitro study found andrographis to inhibit the growth of bacteria like Staphylococcus aureus, which can lead to antibiotic-resistant infections, Escherichia coli, which can cause digestive distress, Vibrio cholerae, which causes cholera, and Salmonella typhi, which causes typhoid fever.3

Andrographis can also be useful in helping to break down biofilms, which shield bacteria from the efforts of the immune system and antibiotics.4

Antiviral Activity

Andrographolide is a biologically active compound in andrographis that is known for its broad-spectrum antiviral properties. It has been proposed that andrographolide intervenes in multiple steps of the viral life cycle, including viral entry, genetic material replication, and protein synthesis.5

Andrographolide has shown in vitro activity against viruses like herpes simplex 1, Epstein-Barr, and influenza A.6

More recently, in vitro studies have demonstrated the inhibitory effect of andrographolide against SARS-CoV-2, the causative agent of COVID-19.5

Antifungal and Antiparasitic Activity

In folk medicine, andrographis has been used for fungal infections for centuries. Preliminary in vitro studies justify this use, especially in relation to fungal skin infections.2,7

Likewise, in vitro studies indicate andrographis can be of benefit when used against various parasites.4

In a 2013 animal study, andrographis extract exerted antimalarial activity in mice infected with Plasmodium berghei, a parasite that causes malaria in certain rodents. In vitro studies have also suggested that andrographis has antimalarial action.4,8

Enhanced Immune Function

Andrographis is well known for having an affinity for respiratory infections as well as being able to shorten the duration of an illness.6 Its antimicrobial qualities and its ability to modulate the immune system make this possible.

A systematic review of randomized controlled trials concluded that andrographis is beneficial in shortening the duration of and improving acute respiratory tract infection symptoms.9

Additionally, andrographolide has demonstrated direct and indirect effects against cancer cells in in vitro studies, including inhibiting the proliferation of cancer cells and inducing the destruction of cancer cells.2

Liver Protection and Function

Andrographis is widely used to protect the liver and support its function. Thanks to its bitter phytochemical compounds, andrographis can stimulate liver enzymes and promote healthy bile flow, which in turn, enhances digestion and detoxification.

Andrographis’s liver-protective qualities have been well documented in modern scientific research. A 2014 animal study showed andrographis extract exerts hepatoprotective effects in acute liver toxicity situation. It was proposed that this effect was due to the herb’s ability to fight free radicals, inhibit cellular proliferation, and induce a form of programmed cell death known as apoptosis.10

In a 2020 animal study, andrographis extract reduced oxidative stress and liver damage in mice.11

leaves of andrographis paniculata, commonly known as creat or green chiretta, Acanthaceae, pathogen inactivation on coronaviruses is very important, note select focus

Joint Health and Comfort

Andrographis may be better known for its antimicrobial and liver-protective properties, but it also has the impressive benefit of easing joint discomfort. Much of this ability is due to the way it can calm overactive immune and inflammatory responses. A double-blind, placebo-controlled human study administered andrographis extract to rheumatoid arthritis (RA) patients three times a day. After 14 weeks, RA patients experienced decreased joint pain.12

Animal studies show that andrographis has multiple anti-inflammatory actions that contribute to this effect. It reduces pro-inflammatory cytokines but can also encourage cell death of immune cells in joints that cause excess inflammation and tissue damage.13

Healthy Energy Levels

In a 2016 double-blind, placebo-controlled human clinical trial, multiple sclerosis (MS) patients receiving interferon beta treatment were given 170 mg of andrographis extract or placebo two times daily over a period of 12 months. MS patients taking the andrographis extract had a significant reduction in fatigue compared to placebo.14 Although the exact mechanisms of action are unknown, the authors of the study suggest that the herb’s anti-inflammatory and neuroprotective effects may contribute to the reduction in fatigue.

History & Traditional Use

Andrographis has a long history of use in traditional systems of medicine like Ayurveda, Unani, and traditional Chinese medicine (TCM). Across the board, andrographis has been relied on to enhance immune function, resist infections, support digestion, and protect the liver.

In Ayurveda, an ancient Indian medical system, andrographis is a common ingredient in herbal formulations used for liver conditions.15 It is also commonly used to increase appetite and strengthen digestion. The leaf juice is a traditional household remedy for stomach distress, but it is also used to remove parasites, promote bile flow, and reduce fever. Just after the Spanish flu of 1918, the Indian flu hit in 1919, and andrographis was used widely and largely credited with helping halt the spread of the epidemic.

From a TCM perspective, the bitter qualities of andrographis, or chuan xin lian, are believed to clear heat from the blood, which can look like infections or toxins. It is specifically used in cases of colds, flu, fever, cough, skin conditions, bronchitis, tonsillitis, and many more conditions.6

In Malaysia, a decoction of the aerial parts is used for the common cold, hypertension, diabetes, cancer, malaria, and snakebites.16

How to Use and Dosing

Andrographis paniculata or Kariyat leaf plant with herb capsules to treating covid-19 coronavirus viral infection.

The Ayurvedic name for andrographis translates to “king of bitters,” so it is often preferred and best taken in capsule form to avoid its bitter taste.

A standardized extract of andrographis is ideal and should be standardized to 10% to 30% andrographolides. General dosing for a standardized extract is 200-800 mg, two to three times daily. If using a tincture, ​​1.5-3 mL, 2-4 times daily is standard.

To enhance immune function, andrographis can be combined with reishi mushroom, lion’s mane mushroom, cat’s claw, Japanese knotweed, garlic, Chinese skullcap, turmeric, cordyceps, astragalus, and echinacea.

For added liver support, consider pairing andrographis with herbs like milk thistle, turmeric, schisandra, and dandelion root.

Interactions

There are no known significant interactions, however, animal studies suggest andrographis may modify glucose regulation, so be aware if using hypoglycemic drugs.

Always check with your health care practitioner before use if you are taking medications. For more general education on potential interactions between herbs and medications, check out Dr. Bill Rawls’ article: Is it Safe to Take Herbs with My Medications?

Precautions & Side effects

About 1% of people who take andrographis develop an allergic reaction with whole-body hives and itching skin. The reaction will resolve gradually over several weeks after stopping the use of the herb.

Avoid the use of this herb during pregnancy.

Disclaimer: This information is intended only as general education and should not be substituted for professional medical advice. Any mentioned general dosage options, safety notices, or possible interactions with prescription drugs are for educational purposes only and must be considered in the context of each individual’s health situation and the quality and potency of the product being used. Use this information only as a reference in conjunction with the guidance of a qualified healthcare practitioner.

Category:

Herbs, research, Treatment

Comments Off on Andrographis